Kura Oncology Inc (KURA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Kura Oncology Inc   (NASDAQ: KURA)
 

Kura Oncology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Kura Oncology Inc 's inventory turnover ratio sequentially decreased to 0.54 in the second quarter 2026, otherwise the ratio remained above the average, as KURA's markets remain strong.Kura Oncology Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 676 days, from 440 days, in the Mar 31 2026 quarter.

Within Healthcare sector Kura Oncology Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

KURA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Kura Oncology Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KURA Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.54 0.83 - - -
KURA's Total Ranking # # # # #
Average inventory processing period 676 437 - - -
Seq. Inventory Growth 194.78 % 104.12 % - - -
Seq. Cost of Sales Growth -7.25 % - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



KURA Company Profile >> Back to KURA Efficiency Comparisons >> Compare KURA Inventory Turnover Ratio to its Competitors

Financial Statements
Kura Oncology Inc 's Inventories $ 2 Millions Visit KURA's Balance sheet
Kura Oncology Inc 's Cost of Revenues TTM $ 1 Millions Visit KURA's Income Statement
What are KURA's Sales? Visit KURA's Sales by Segment

Other Inventory Turnover Ratios
Kura Oncology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KURA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KURA's Competitors
Inventory Turnover Ratio for KURA's Suppliers
Inventory Turnover Ratio for KURA's Customers

You may also want to know
KURA's Sales Growth Rates KURA's Pe Price to earnings ratio KURA's Receivables Turnover Ratio KURA's Stock Quote
KURA's Net Income Growth Rates KURA's Ps Price to Sales ratio KURA's Sales per Employee KURA's Asset Turnover Ratio
KURA's Net Margin KURA's Pb Price to Book ratio KURA's Financial Strength Ratios KURA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Ionis Pharmaceuticals Inc   0.53 $ 9.873  Millions$ 19  Millions
Heron Therapeutics Inc   0.53 $ 45.572  Millions$ 86  Millions
Orchestra Biomed Holdings Inc   0.52 $ 0.157  Millions$ 0  Millions
Sintx Technologies Inc   0.51 $ 0.627  Millions$ 1  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions

Date modified: 2026-09-03T23:54:00+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.